Ignite Creation Date:
2025-12-24 @ 4:34 PM
Ignite Modification Date:
2026-01-02 @ 9:39 AM
Study NCT ID:
NCT04302766
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2022-02-17
First Post:
2020-03-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Remdesivir (RDV; GS-5734™)
Sponsor:
U.S. Army Medical Research and Development Command
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2020-03-02
First Submit QC Date:
None
Study First Post Date:
2020-03-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-15
Last Update Post Date:
2022-02-17
Last Update Post Date Type:
ACTUAL